Experts urge health regulators to approve "turning point" dementia drugs

Health regulators are being urged to rapidly approve two gamechanging dementia drugs in order to ensure millions of people who could benefit are not left in limbo, after more stunning trial data. The final results from a landmark study confirmed that donanemab, made by Eli Lilly, slowed cognitive decline in Alzheimer’s patients by 35%. Trial results published last year showed that a second drug, lecanemab, made by Eisai and Biogen, reduced the rate by 27%. Health leaders hailed the arrival of the drugs as a turning point in the fight against Alzheimer’s, through which the disease could become just as manageable as conditions such as diabetes or asthma.

tips

urge：极力主张；迫切要求

dementia：痴呆

dement：使发狂（ment- = mind，思考，神智）

limbo：处于不定状态

landmark：划时代的事，里程碑

cognitive：认知的

hail：打招呼；冰雹；赞扬

diabetes：糖尿病

asthma：哮喘病